1993
DOI: 10.1378/chest.103.6.1763
|View full text |Cite
|
Sign up to set email alerts
|

Augmented Resting Sympathetic Activity in Awake Patients With Obstructive Sleep Apnea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
368
2
23

Year Published

1997
1997
2022
2022

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 608 publications
(403 citation statements)
references
References 21 publications
10
368
2
23
Order By: Relevance
“…Regardless of the method used, essentially all studies have reported that OSA is associated with increased sympathetic activity. 20,22,24,25 Furthermore, unlike the situation in normal subjects, blood pressure 26 and sympathetic activity remain high during sleep in OSA patients. These findings highlight the challenges of using autonomic signals to detect sleep stages in OSA patients.…”
Section: Light/deep Sleep Detectionmentioning
confidence: 98%
“…Regardless of the method used, essentially all studies have reported that OSA is associated with increased sympathetic activity. 20,22,24,25 Furthermore, unlike the situation in normal subjects, blood pressure 26 and sympathetic activity remain high during sleep in OSA patients. These findings highlight the challenges of using autonomic signals to detect sleep stages in OSA patients.…”
Section: Light/deep Sleep Detectionmentioning
confidence: 98%
“…The first included eleven obese OSA patients 28 who were not fully matched to the healthy control subjects for age or BMI. NPY in the OSA patients was not increased and the authors explained their negative results by the low sympathetic nerve activity (SNA) of the patients they included, as NPY is a marker of sympathetic activation.…”
Section: Neuropeptides and Impaired Glucose Tolerancementioning
confidence: 99%
“…In type 2 diabetic patients, euglycemic-hyperinsulinemic clamp studies similarly show evidence of improved insulin sensitivity with CPAP (90), with evidence as well of improvement in postprandial glycemia in those using CPAP Ͼ4 h/night, with progressive improvement in A1C in these persons over a 5-month period of treatment (91) and evidence of improved glycemic patterns with continuous glucose monitoring studies. The mechanisms of adverse effect of OSA appear to involve sympathetic activation, with increased muscle sympathetic activity in persons with OSA with and without hypertension and with increased circulating norepinephrine levels (92), with sympathetic nerve activity and blood pressure increased during periods of nocturnal wakefulness, responding to CPAP treatment (93). Experimental sleep deprivation is associated with increased serum cortisol levels on the following evening (83), another potential mechanism of adverse metabolic effect, with CPAP reversing the hypercortisolemia (94).…”
Section: Nonalcoholic Fatty Liver Diseasementioning
confidence: 99%